|
biomedicina slovenica |
"INTERFERON-BETA" : 25
-
Stopinšek Sanja; Simčič Saša; Plankl Mojca; Rot Uroš; Ihan Alojz
Uporaba rezultatov o nevtralizirajočih protitelesih proti interferonu-beta pri bolnikih z multiplo sklerozo
2013 ►
-
Fajs Luka; Resman Rus Katarina; Avšič-Županc Tatjana
Crimean-Congo hemorrhagic fever virus nucleoprotein suppresses IFN-beta-promoter-mediated gene expression
2013 ►
-
Hartung HP; Freedman MS; Polman CH; Šega-Jazbec Saša
Interferon beta-1b-neutralizing antibodies 5 years after clinically isolated syndrome
2011 ►
-
O'Connor Paul; Filippi Massimo; Arnason Barry; Šega-Jazbec Saša
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
2009 ►
-
Kappos Ludwig; Freedman Mark S; Polman Chris H; Šega Jazbec Saša
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial
2009 ►
-
Rot U; Sominanda A; Fogdell-Hahn A; Hillert J
Impression of clinical worsening fails to predict interferon-beta neutralizing antibody status
2008 ►
-
Šega Saša; Horvat Alenka; Rot Uroš; Wraber Branka; Ihan Alojz
Could cytokines levels or adhesion molecules expression be predictor of IFN-beta treatment response in multiple sclerosis patients?
2008 ►
-
Sominanda A; Rot U; Suoniemi M; Deisenhammer F; Hillert J; Fogdell-Hahn A
Interferon beta preparations for the treatment of multiple sclerosis patients differ in neutralizing antibody seroprevalence and immunogenicity
2007 ►
-
Šega Saša; Horvat Alenka; Popović Mara
Anaplastic oligodendroglioma and gliomatosis type 2 in interferon-beta treated multiple sclerosis patients: report of two cases
2006 ►
-
Šega-Jazbec Saša
Primerjava vpliva terapije z interferonom beta-1a in interferonom beta-1b na potek bolezni, citokine in adhezijske molekule pri bolnikih z recidivno-remitentno multiplo sklerozo
2005 ►
-
van Holten J; Pavelka K; Vencovsky J; Stahl H; Rozman B; Genovese M; Kivitz AJ; ALvaro J; Nuki G; Furst DE
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1-a in the treatment of patients with active rheumatoid arthritis
2005 ►
-
Liščić Rajka M; Brecelj Jelka
Visual evoked potentials in multiple sclerosis patients treated with interferon beta-1a
2004 ►
-
Perišić S; Perišić Z; Tasić L; Vasiljević M
Treatment of condylomata acuminata - surgical excision and CO2 laser vaporization
2004 ►
-
Horvat-Ledinek Alenka
Primerjava uspešnosti zdravljenja bolnikov z multiplo sklerozo z interferonom beta-1b in glatiramer acetatom
2001 ►
-
Horvat Alenka
Zdravljenje multiple skleroze
2000 ►
-
Fleischmann W Robert Jr; Koren Srečko
Systemic effects of orally administered interferons and interleukin-2
1999 ►
-
Končan-Vračko Beatrika
Napredek znanosti v zdravljenju oseb z multiplo sklerozo: novosti v letu 1998
1998 ►
-
Meh Duška; Denišlič Miro
Interferon beta-1B
1996 ►
-
Denišlič M; Šega-Jazbec S
Zdravljenje multiple skleroze
1996 ►
-
Štalc A
Pregled v zdravljenje uvedenih rekombinantnih zdravil
[A review of recombinant drugs introduced into the therapy]
1996 ►
-
Denišlič M
Betaferon pri zdravljenju bolnikov z multiplo sklerozo
1996 ►
-
Baumhackl U
Management of multiple sclerosis patients with interferon beta-therapy - experience from Austria
1995 ►
-
Koren S; Fleischmann WR Jr
Orally administered interferons suppress bone marrow function (43646)
1993 ►
-
Cencič A; Filipič B
Biological activity of rat fibroblast interferon beta
1993 ►
-
Kotnik V; Fleischmann WR Jr
IFN alpha/beta, IFN gamma, TNF alpha and combinations of IFN gamma/TNF alpha as C57B1/6 mice bone marrow cells proliferation inhibitors and differentiation factors
1990 ►
New search
Comments
Top of page
Institute for Biostatistics and Medical Informatics